文献速递胸部儿科影像妇产影像CTUS

肺部超声可能有助于COVID-19肺炎的诊断与监测

Lung Ultrasound May Support Diagnosis and Monitoring of COVID-19 Pneumonia.
PubMed 文献 · Ultrasound Med Biol · 2020-07-20

严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)疾病(COVID-19)约20%的感染者表现为重症肺炎和/或急性呼吸窘迫综合征。CT是COVID-19肺炎诊断和监测的常规影像技术,敏感度高但普及性有限、需转运患者、使用后需消毒,且因辐射顾虑在儿童和孕妇中使用不足。肺部超声(LUS)是一种新兴的床旁无创技术,通过评估和量化B线数量、胸膜不规则及结节或实变来诊断间质性肺综合征。在COVID-19肺炎患者中,LUS呈现典型的弥漫性间质性肺综合征模式,表现为多发或融合的双侧B线伴保留区、胸膜线增厚伴胸膜线不规则及外周实变。LUS诊断COVID-19肺炎有前景,其表现与胸部CT相关性尚可,并具有无辐射、床旁可重复、低成本、适用于低资源环境等优势,可能减少常规影像资源(CT和胸部X线)的使用,有助于早期诊断、治疗决策和随访监测,尤其在重症监护环境及孕妇、儿童和社区传播率高地区的患者中。

要点

  • COVID-19肺炎的LUS典型模式为弥漫性间质性肺综合征:多发或融合的双侧B线伴保留区、胸膜线增厚且不规则、外周实变。
  • LUS表现与胸部CT相关性尚可,可作为床旁无创工具辅助诊断。
  • LUS无辐射、可床旁重复、成本低,尤其适用于孕妇、儿童及低资源环境。

核心结论

  • LUS可能有助于COVID-19肺炎的早期诊断、治疗决策和随访监测,尤其在重症监护环境以及孕妇、儿童和社区传播率高地区的患者中。

研究设计与样本

  • 本文为综述,讨论LUS在COVID-19肺炎诊断与监测中的应用价值,未报告系统检索范围与纳入文献数量。

关键影像表现/征象

  • COVID-19肺炎的LUS典型表现为弥漫性间质性肺综合征:多发或融合的双侧B线伴保留区。
  • 胸膜线增厚伴胸膜线不规则。
  • 可见外周实变。

诊断标准与关键数值

  • LUS通过评估和量化B线数量、胸膜不规则及结节或实变来诊断间质性肺综合征。

临床应用与阅片要点

  • LUS表现与胸部CT相关性尚可,可作为COVID-19肺炎的床旁无创评估工具。
  • LUS无辐射、可床旁重复、成本低,适用于低资源环境,并可能减少CT和胸部X线的使用。
  • 对孕妇、儿童及社区传播率高地区的患者,LUS可能有助于早期诊断、治疗决策和随访监测。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) is characterized by severe pneumonia and/or acute respiratory distress syndrome in about 20% of infected patients. Computed tomography (CT) is the routine imaging technique for diagnosis and monitoring of COVID-19 pneumonia. Chest CT has high sensitivity for diagnosis of COVID-19, but is not universally available, requires an infected or unstable patient to be moved to the radiology unit with potential exposure of several people, necessitates proper sanification of the CT room after use and is underutilized in children and pregnant women because of concerns over radiation exposure. The increasing frequency of confirmed COVID-19 cases is striking, and new sensitive diagnostic tools are needed to guide clinical practice. Lung ultrasound (LUS) is an emerging non-invasive bedside technique that is used to diagnose interstitial lung syndrome through evaluation and quantitation of the number of B-lines, pleural irregularities and nodules or consolidations. In patients with COVID-19 pneumonia, LUS reveals a typical pattern of diffuse interstitial lung syndrome, characterized by multiple or confluent bilateral B-lines with spared areas, thickening of the pleural line with pleural line irregularity and peripheral consolidations. LUS has been found to be a promising tool for the diagnosis of COVID-19 pneumonia, and LUS findings correlate fairly with those of chest CT scan. Compared with CT, LUS has several other advantages, such as lack of exposure to radiation, bedside repeatability during follow-up, low cost and easier application in low-resource settings. Consequently, LUS may decrease utilization of conventional diagnostic imaging resources (CT scan and chest X-ray). LUS may help in early diagnosis, therapeutic decisions and follow-up monitoring of COVID-19 pneumonia, particularly in the critical care setting and in pregnant women, children and patients in areas with high rates of community transmission.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Allinovi M, Parise A, Giacalone M, et al. Lung Ultrasound May Support Diagnosis and Monitoring of COVID-19 Pneumonia. Ultrasound Med Biol. 2020. PMID: 32807570. doi:10.1016/j.ultrasmedbio.2020.07.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。